#Italy #Innovation #Rome #Haier Biomedical #European Summit

Haier Biomedical's European Partner Summit in Rome

Haier Biomedical recently organized its European Partner Summit in Rome under the theme "Advancing Together: Sharing the Future of Biomedical Innovation." The event gathered 37 regional partners and industry leaders from 23 European countries to discuss their long-term commitment to Europe and unveil an expanded laboratory solutions portfolio. This represents a strategic upgrade in their brand offerings aimed at developing scenario-based and application-centered solutions.

The summit also highlighted Haier Biomedical's strategy, which emphasizes localizing services and support across Europe. Enrique Wang, the company's Global Market Director, stated the goal of achieving over 50% of global revenue from international markets by 2027, as well as contributions beyond refrigeration by 2028. He emphasized the significance of Europe within the company’s globalization roadmap, adhering to the principle of delivering products, services, and support in accordance with local regulatory standards and customer expectations.

Semir Selimovic, Director for Northern, Central, and Eastern Europe, spoke about the European strategy for 2026, focusing on ongoing investments in local sales, service, and product expertise to enhance responsiveness in key markets. Europe has become one of Haier Biomedical's fastest-growing international regions, supported by local team expansions and an ever-growing product range.

Among the new products introduced at the summit, the XJ-III Plasma Apheresis System gained notable attention after receiving EU MDR certification, marking a significant milestone in meeting Europe's stringent regulatory requirements. Haier Biomedical’s CO₂ incubators, centrifuges, biosafety cabinets, and cold storage lines continue to capture market share due to their energy-efficient technologies and compliance with local certification standards. The product evolution showcased in Rome reflects progress toward creating a comprehensive portfolio that can support laboratories, hospitals, and life science institutions with integrated solutions.

Daniele Pericolini, a European Solutions Automation Specialist at Haier Biomedical, detailed strategies aimed at fostering future growth through laboratory automation and intelligent blood management systems. The company’s automated biobank solutions merge ultra-low temperature storage with RFID technology, modular automation platforms, and liquid nitrogen systems to enhance sample traceability and operational efficiency. In response to challenges like sample integrity and temperature monitoring, the company is positioning itself to meet the increasing European demand for advanced biobank infrastructure.

Moreover, the U-Blood intelligent blood management system represents a shift from traditional cold storage to real-time connected blood supply chain management, designed to reduce waste, improve traceability, and facilitate 24-hour transfusion workflows. This aligns with the growing European focus on safety, digitization, and zero-waste healthcare initiatives.

The summit also celebrated success stories from four European partners representing Germany, Slovenia, France, and Denmark, underscoring local validation of Haier Biomedical’s solutions. In France, a longstanding partner highlighted a jointly developed biosafety cabinet adapted to French standards, with over 230 units implemented for more than 100 clients. In Denmark, another partner shared their success with ultrafreezers acquired through public tenders, leading to ongoing expansion into new product categories. Large-scale pharmaceutical facilities in Slovenia strengthened the company's capacity to manage complex multi-unit projects, while Central European partners emphasized reliability, regulatory compliance, and after-sales support as key differentiators.

In 2025, Haier Biomedical’s strong international performance positioned it to achieve revenues exceeding 2.3 billion RMB, with international revenues hitting 840 million RMB—over 36% of total income, illustrating its ongoing global expansion. Europe experienced double-digit growth, significantly contributing to the overall increase in international revenues. The company’s AI and automation-based solutions generated approximately 15% of total revenues in 2025, reflecting a technological transformation from hardware exports to localized solution delivery supported by regional teams and certifications across 18 countries.

As the European Partner Summit concluded, Haier Biomedical reaffirmed its dedication to enhancing local operations, expanding automation and life sciences solutions, and promoting collaborative growth with partners. By merging global innovation capabilities with local execution in Europe, the company aims to further cement its status as a trusted provider of life sciences solutions moving into 2026. For more information, visit Haier Medical.
Video of the event